Aarti Pharmalabs has informed that the Company has received from Constituted Attorney(ies) representing the Persons prescribed in Schedule I of Annexure to the agreement an intimation under Regulation 30A(1) of the Listing Regulations read with Clause 5A, Para A, Part A, Schedule III of the Listing Regulations on December 16, 2024. The details as required pursuant to Regulation 30 read with Schedule Ill of the Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 are also mentioned in the attached agreement. The below information will also be available on the website of the Company at www.aartipharmalabs.com.
The above information is a part of company’s filings submitted to BSE.
